ACAD
Acadia Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
6.45 / 10
Outperform
Technical analysis rates Outperform with a 6.45/10 score. MACD Death Cross, Long Upper Shadow and Long Lower Shadow provide modest bullish signals, but overall market volatility limits clear direction, resulting in a cautiously optimistic technical stance.
Analysis Checks(3/3)
Long Upper Shadow
Score7.15/10
Win Rate71.43%
Hist. Signals7
Avg Return-0.17%
Score7.15/10
Win Rate71.43%
Hist. Signals7
Avg Return-0.17%
MACD Death Cross
Score6.16/10
Win Rate62.50%
Hist. Signals8
Avg Return0.03%
Score6.16/10
Win Rate62.50%
Hist. Signals8
Avg Return0.03%
Long Lower Shadow
Score6.05/10
Win Rate54.55%
Hist. Signals11
Avg Return2.78%
Score6.05/10
Win Rate54.55%
Hist. Signals11
Avg Return2.78%
Long Upper Shadow
Score7.15/10
Win Rate71.43%
Hist. Signals7
Avg Return-0.17%
Score7.15/10
Win Rate71.43%
Hist. Signals7
Avg Return-0.17%
Long Lower Shadow
Score6.05/10
Win Rate54.55%
Hist. Signals11
Avg Return2.78%
Score6.05/10
Win Rate54.55%
Hist. Signals11
Avg Return2.78%
MACD Death Cross
Score6.16/10
Win Rate62.50%
Hist. Signals8
Avg Return0.03%
Score6.16/10
Win Rate62.50%
Hist. Signals8
Avg Return0.03%
What is the current technical signals for ACAD?
- ACAD presents a Outperform setup with a Technical Score of 6.45/10. Key technical indicators highlight an RSI of 40.04 and a MACD of 0.17, with the trend anchored by the 50-Day SMA at 23.48. Traders should monitor key support at 21.29 and resistance at 21.80.
